Celularity (CELU) Enterprise Value (2019 - 2025)

Celularity (CELU) has reported Enterprise Value for 7 consecutive years, with $25.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Enterprise Value fell 58.89% year-over-year to $25.8 million in Q4 2025; TTM through Dec 2025 was $25.8 million, a 58.89% decrease from a year earlier, with the FY2025 full-year figure at $25.8 million, down 58.89% from the prior year.
• Enterprise Value was $25.8 million for Q4 2025 at Celularity, down from $58.3 million in the prior quarter.
• Over five years, Enterprise Value peaked at $1.2 billion in Q1 2022 and troughed at $25.8 million in Q4 2025.
• A 5-year average of $236.5 million and a median of $94.5 million in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value soared 217.91% in 2022 and tumbled 91.86% in 2023, its largest moves.
• Over 5 years, Enterprise Value stood at $306.1 million in 2021, then sank by 41.8% to $178.1 million in 2022, then plunged by 73.26% to $47.6 million in 2023, then soared by 31.93% to $62.8 million in 2024, then slumped by 58.89% to $25.8 million in 2025.
• The last three Enterprise Value figures came in at $25.8 million (Q4 2025), $58.3 million (Q3 2025), and $59.1 million (Q2 2025), per Business Quant data.